Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
World Health Organization
Biotech
Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO
Officials are planning to study Mapp Biopharmaceutical’s MBP134 and Gilead Sciences’ remdesivir, which saw widespread use against COVID-19.
Eric Sagonowsky
Jun 24, 2026 3:03pm
Novo Nordisk Foundation pledges $31M for pandemic preparedness
Oct 14, 2025 10:00am
WHO: Poor R&D distribution among nations hurts pandemic prep
Oct 31, 2023 10:55am
Oxford malaria vaccine maintains high efficacy with booster
Sep 8, 2022 11:00am
Moderna is feeling the pressure to address monkeypox: R&D chief
Aug 3, 2022 10:20am
Clover's COVID booster bolsters antibody levels against omicron
Jun 27, 2022 11:10am
